Development of site-specific ARG-glcnac antibodies

Ended Project Grant Awarded Last action

Award ID
R43GM133288
Recipient
Awarding agency
Obligated
$298,483

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date
Originally
Place of performance
Georgia, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Development of site-specific ARG-GLCNAC antibodies - human pathogenic gram-negative bacteria, such as escherichia coli (E. Coli) and salmonella enterica cause… $0
Amendment $148,483
Original award $150,000

Quick answers

Who received award R43GM133288?

R43GM133288 was awarded to Glycoscientific, L.L.C. by National Institute of General Medical Sciences (National Institutes of Health) on May 2, 2019.

How much is award R43GM133288 worth?

$298,483 has been obligated on R43GM133288.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award